The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE INITIATION OF TREATMENT OF UNMANAGEABLE PSYCHOTICS WITH INTRAMUSCULAR ADMINISTRATION OF TRIFLUOPERAZINE COMBINED WITH CHLORPROMAZINE

Published Online:https://doi.org/10.1176/ajp.120.1.74

A combined intramuscular administration of trifluoperazine with chlorpromazine was used in 36 highly psychotic male patients aged 15 to 51. Remarkable improvement was observed within from 1 to 3 days of treatment, depending on the degree of disturbance. There were only 2 patients who needed a higher or a lower dosage, respectively, the average being 2 mg. of trifluoperazine and 50 mg. of chlorpromazine.

The advantages of the intramuscular combination of these drugs are 1. An almost immediate response to the medication; 2. Shortening or elimination of seclusion or restraining periods; 3. Shortening of the initial phase of hospitalization; 4. Speeding of the patient's readiness for intensive psychotherapy and oral medication; 5. Benefit to other patients who are not subjected to witnessing severely-disturbed behavior of others; 6. Lessening of anxiety and nursing problems for attending personnel in the ward.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.